← Leaderboards
Manfred R Koller
Cyntellect, Inc.
$8,512,157
Attributed
$8,512,157
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$8,512,157 · 4
By mechanism
R44$8,130,252 · 2
R43$381,905 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Lasers”
- Albert Lazzarini · California Institute Of Technology$322,785,989
- David H Reitze · University Of Florida$319,789,440
- Peter K Fritschel · California Institute Of Technology$78,820,000
- David H Shoemaker · California Institute Of Technology$68,727,967
- Eric Baer · Case Western Reserve University$37,136,000
- Philip J Reid · University Of Washington$36,331,320
Research focus
LasersBioengineering /Biomedical EngineeringBiomedical Equipment DevelopmentTissue /Cell PreparationCell SortingOpticsCytodiagnosisImage ProcessingBioimaging /Biomedical ImagingHigh Throughput TechnologyGene Induction /RepressionFunctional /Structural GenomicsReagent /IndicatorInjection /InfusionTechnology /Technique DevelopmentNew World ArenavirusNuclear Factor Kappa BetaNucleic Acid HybridizationNucleic Acid PurificationOligonucleotidesPosttranscriptional Rna ProcessingRna InterferenceSmall Interfering RnaThiophosphate
Grant awards (8)
Gene silencing by optoinjection and RNA interface$637,894
R44 · FY2005 · HG
Gene silencing by optoinjection and RNA interface$777,955
R44 · FY2004 · HG
LASER CELL PROCESSING FOR BASIC AND CLINICAL RESEARCH$1,775,351
R44 · FY2003 · RR
Gene silencing by optoinjection and RNA Interference$183,150
R43 · FY2003 · HG
LASER CELL PROCESSING FOR BASIC AND CLINICAL RESEARCH$1,990,955
R44 · FY2002 · RR
Aptamer Screening for Bioterrorism Agent Therapeutics$198,755
R43 · FY2002 · AI
LASER CELL PROCESSING FOR BASIC AND CLINICAL RESEARCH$2,094,963
R44 · FY2001 · RR
LASER CELL PROCESSING FOR BASIC AND CLINICAL RESEARCH$853,134
R44 · FY2000 · RR